FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Simes

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Geographic Areas

Australia

Co-author Network

Publications

TOP 3
C K Lee; Sarah J Lord; M Nankivell; G Parma; J Pfisterer; C Pisano; M Plante; Eric Pujade-Lauraine; C Schauer; R John Simes; T Skeie-Jensen; A-M Swart; Ignace Vergote; K Baumann; A Belau; J Bentley; D Berton-Rigaud; C Brown; U Canzler; Val Gebski; G Kristensen; Christian Kurzeder; J A Ledermann; M Friedlander
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.
Rachel F Dear; Alison Evans; Catherine Holliday; George Hruby; Dan Kent; John Newsom; Eva Segelov; R John Simes; Alexandra Barratt; Sally Crossing; Martin H N Tattersall
Identifying and prioritising gaps in colorectal cancer trials research in Australia.
Anthony C Keech; Jordan R Fulcher; R John Simes
The role of statin therapy in patients with lower vascular risk.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Simes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: C K Lee; Sarah J Lord; M Nankivell; G Parma; J Pfisterer; C Pisano; M Plante; Eric Pujade-Lauraine; C Schauer; R John Simes; T Skeie-Jensen; A-M Swart; Ignace Vergote; K Baumann; A Belau; J Bentley; D Berton-Rigaud; C Brown; U Canzler; Val Gebski; G Kristensen; Christian Kurzeder; J A Ledermann; M Friedlander
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):937-43.
2012: Rachel F Dear; Alison Evans; Catherine Holliday; George Hruby; Dan Kent; John Newsom; Eva Segelov; R John Simes; Alexandra Barratt; Sally Crossing; Martin H N Tattersall
Identifying and prioritising gaps in colorectal cancer trials research in Australia.
The Medical journal of Australia 2012;197(9):507-11.
2012: Anthony C Keech; Jordan R Fulcher; R John Simes
The role of statin therapy in patients with lower vascular risk.
The Medical journal of Australia 2012;197(3):130-1.
2012: Chee Khoon Lee; Ian C Marschner; R John Simes; Merryn Voysey; Brian Egleston; Gary Hudes; Paul de Souza
Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimus.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(11):3188-96.
2012: Andrew Tonkin; Merryn Voysey; Jonathon Waites; Peta Forder; Paul Glasziou; Andrew Hamer; David Hunt; Anthony C Keech; Antero Kesäniemi; Leo Mahar; Stewart Mann; R John Simes
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
American heart journal 2012;163(3):508-14.
2012: Ru-Dee Ting; David Celermajer; Timothy M E Davis; Mark W Donoghoe; Paul L Drury; John Hedley; Alicia J Jenkins; Anthony C Keech; Seppo Lehto; Kushwin Rajamani; R John Simes; Kim Stanton
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study.
Diabetes care 2012;35(2):218-25.
2012: Lukas P Staub; Sarah J Lord; R John Simes; Robert Y M Chen; Suzanne Dyer; Nehmat Houssami; Les Irwig
Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation.
BMC medical research methodology 2012;12():12.
2012: Lukas P Staub; Suzanne Dyer; Sarah J Lord; R John Simes
Linking the evidence: intermediate outcomes in medical test assessments.
International journal of technology assessment in health care 2012;28(1):52-8.
2011: Martin R Stockler; Guy Van Hazel; Nicholas Wilcken; Diana Zannino; Stephen P Ackland; Michael J Byrne; Bernie Fitzharris; Akiko Fong; John F Forbes; Prudence A Francis; M Corona Gainford; Val Gebski; Peter S Grimison; Vernon J Harvey; Anna K Nowak; Lisa Paksec; R John Simes; Tatiana Sourjina; Alan S Coates
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(34):4498-504.
2011: C K Lee; S Lord; G Parma; J Pfisterer; C Pisano; M Plante; E Pujade-Lauraine; B Richter; R John Simes; Ignace Vergote; U Wagner; L Angleitner-Boubenizek; J Bentley; H Bourgeois; C Brown; A Burges; A Ferrero; Val Gebski; H Hirte; T Högberg; M Friedlander
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.
British journal of cancer 2011;105(8):1144-50.
2011: Chee K Lee; Sarah J Lord; Mansoor Raza Mirza; Sandro Pignata; Eric Pujade-Lauraine; Philippe Sauthier; Barbara Schmalfeldt; Chris Brown; Rémy Delva; Nicoletta Donadello; Michael Friedlander; Val J Gebski; Alexander Georgoulopoulos; Ignace Vergote; R John Simes
Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer.
Journal of the National Cancer Institute 2011;103(17):1338-42.
2011: C K Lee; S Lord; Martin R Stockler; S Ackland; F Boyle; Alan Coates; M Friedlander; Val Gebski; M Hudson; R John Simes
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer.
Breast cancer research and treatment 2011;129(2):467-76.
2011: C K Lee; S Lord; J Maenpaa; W Meier; E Petru; E Pujade-Lauraine; N Reed; R John Simes; R Sorio; G Tulunay; M Bacon; C Brown; N Donadello; Val Gebski; H Gurney; M Friedlander
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
British journal of cancer 2011;105(3):360-5.
2011: Katrin M Sjoquist; B Mark Smithers; John R Zalcberg; Andrew Barbour; Bryan H Burmeister; Val Gebski; R John Simes
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
The lancet oncology 2011;12(7):681-92.
2011: Rachel F Dear; Alexandra Barratt; Kevin McGeechan; Lisa Askie; R John Simes; Martin H N Tattersall
Landscape of cancer clinical trials in Australia: using trial registries to guide future research.
The Medical journal of Australia 2011;194(8):387-91.
2011: Sanneke P M de Boer; Elizabeth H Barnes; Cynthia M Westerhout; R John Simes; Christopher B Granger; Adnan Kastrati; Petr Widimsky; Menko Jan de Boer; Felix Zijlstra; Eric Boersma
High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration.
American heart journal 2011;161(3):500-507.e1.
2010: Wendy De Roock; Derek J Jonker; Federica Di Nicolantonio; Andrea Sartore-Bianchi; Dongsheng Tu; Salvatore Siena; Simona Lamba; Sabrina Arena; Milo Frattini; Hubert Piessevaux; Eric Van Cutsem; Chris J O'Callaghan; Shirin Khambata-Ford; John R Zalcberg; R John Simes; Christos S Karapetis; Alberto Bardelli; Sabine Tejpar
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.
JAMA : the journal of the American Medical Association 2010;304(16):1812-20.
2010: Marja-Riitta Taskinen; P J Barter; Christian Ehnholm; D R Sullivan; K Mann; R John Simes; J D Best; S Hamwood; A C Keech
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.
Diabetologia 2010;53(9):1846-55.
2010: Peter S Grimison; Martin R Stockler; Damien B Thomson; Ian N Olver; Vernon J Harvey; Val J Gebski; Craig R Lewis; J Levi; Michael J Boyer; Howard Gurney; Paul Craft; Amy L Boland; R John Simes; Guy C Toner
Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
Journal of the National Cancer Institute 2010;102(16):1253-62.
2010: R John Simes; Rachel L O'Connell; Philip E Aylward; Sergei Varshavsky; Rafael Diaz; Robert G Wilcox; Paul W Armstrong; Christopher B Granger; John K French; Frans Van de Werf; Ian C Marschner; Rob Califf; Harvey D White
Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
American heart journal 2010;159(6):988-97.
2010: C K Lee; Martin R Stockler; Alan Coates; Val Gebski; Sarah J Lord; R John Simes
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.
British journal of cancer 2010;102(9):1341-7.
2010: C K Lee; Sarah J Lord; Martin R Stockler; Alan Coates; Val Gebski; R John Simes
Historical cross-trial comparisons for competing treatments in advanced breast cancer--an empirical analysis of bias.
European journal of cancer (Oxford, England : 1990) 2010;46(3):541-8.
2010: Jisheng Cui; Andrew Forbes; Adrienne Kirby; Ian Marschner; R John Simes; David Hunt; Malcolm West; Andrew Tonkin
Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study.
BMC medical research methodology 2010;10():27.
2010: R John Simes; Merryn Voysey; Rachel O'Connell; Paul Glasziou; James D Best; Russell Scott; Christopher Pardy; Karen Byth; David R Sullivan; Christian Ehnholm; Anthony C Keech
A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials.
PloS one 2010;5(1):e8580.
2009: Jisheng Cui; Andrew Forbes; Adrienne Kirby; R John Simes; Andrew Tonkin
Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(6):660-8.
2009: Nicole Mittmann; Heather-Jane Au; Dongsheng Tu; Christopher J O'Callaghan; Pierre K Isogai; Christos S Karapetis; John Zalcberg; William K Evans; Malcolm J Moore; Jehan Siddiqui; Brian Findlay; Bruce Colwell; R John Simes; Peter Gibbs; Matthew Links; Niall C Tebbutt; Derek J Jonker
Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
Journal of the National Cancer Institute 2009;101(17):1182-92.
2009: Peter S Grimison; R John Simes; H Malcolm Hudson; Martin R Stockler
Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(6):967-76.
2009: Michaella J Smith; P Grantley Gill; Neil Wetzig; Tatiana Sourjina; Val Gebski; Owen Ung; Ian Campbell; James Kollias; Xanthi Coskinas; Avis Macphee; Leonie Young; R John Simes; Martin R Stockler
Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
Breast cancer research and treatment 2009;117(1):99-109.
2009: Peter S Grimison; R John Simes; H Malcolm Hudson; Martin R Stockler
Deriving a patient-based utility index from a cancer-specific quality of life questionnaire.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(5):800-7.
2009: Chee K Lee; Sarah J Lord; Alan Coates; R John Simes
Molecular biomarkers to individualise treatment: assessing the evidence.
The Medical journal of Australia 2009;190(11):631-6.
2009: Sue Carrick; Sharon Parker; Charlene E Thornton; Davina Ghersi; R John Simes; Nicholas Wilcken
Single agent versus combination chemotherapy for metastatic breast cancer.
Cochrane database of systematic reviews (Online) 2009;(2):CD003372.
2009: Philip M Clarke; Alison J Hayes; Paul Glasziou; Russell Scott; R John Simes; Anthony C Keech
Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes.
Medical care 2009;47(1):61-8.
2009: Siv Söderberg; D Colquhoun; A Keech; J Yallop; E H Barnes; C Pollicino; R John Simes; A M Tonkin; P Nestel
Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study.
International journal of obesity (2005) 2009;33(1):123-30.
2008: Vlatka M Duric; Phyllis N Butow; Louise Sharpe; Stephane Heritier; Frances M Boyle; Jane Beith; Nicholas R C Wilcken; Alan Coates; R John Simes; Martin R Stockler
Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer.
Patient education and counseling 2008;72(2):239-45.
2008: Paul P Glasziou; Les Irwig; Stephane Heritier; R John Simes; Andrew Tonkin
Monitoring cholesterol levels: measurement error or true change?
Annals of internal medicine 2008;148(9):656-61.
2008: Malcolm J West; Paul J Nestel; Adrienne C Kirby; Renate Schnabel; David Sullivan; R John Simes; Christine Pollicino; Edith Lubos; Thomas Münzel; Harvey D White; Andrew M Tonkin; Christoph Bickel; Laurence Tiret; Stefan Blankenberg
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
European heart journal 2008;29(7):923-31.
2008: Alison J Hayes; Philip M Clarke; Paul Glasziou; R John Simes; Paul L Drury; Anthony C Keech
Can self-rated health scores be used for risk prediction in patients with type 2 diabetes?
Diabetes care 2008;31(4):795-7.
2008: Ralph A H Stewart; Fiona M North; Katrina J Sharples; R John Simes; Andrew M Tonkin; Harvey D White
Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.
The New Zealand medical journal 2008;121(1269):11-23.
2008: Patricia M Kearney; Lisa Blackwell; Rory Collins; Anthony C Keech; R John Simes; Richard Peto; Jane Armitage; Colin Baigent
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
Lancet 2008;371(9607):117-25.
2008: Jisheng Cui; Andrew Forbes; Adrienne Kirby; Ian Marschner; R John Simes; Malcolm West; Andrew Tonkin
Parametric conditional frailty models for recurrent cardiovascular events in the lipid study.
Clinical trials (London, England) 2008;5(6):565-74.
2008: Kerry Dwan; Douglas Altman; Juan A Arnaiz; Jill Bloom; An-Wen Chan; Eugenia Cronin; Evelyne Decullier; Philippa J Easterbrook; Erik von Elm; Carrol Gamble; Davina Ghersi; John Ioannidis; R John Simes; Paula R Williamson
Systematic review of the empirical evidence of study publication bias and outcome reporting bias.
PloS one 2008;3(8):e3081.
2007: Anthony C Keech; Paul Mitchell; P A Summanen; Justin O'Day; Timothy Davis; M S Moffitt; Marja-Riitta Taskinen; R John Simes; D Tse; E Williamson; A Merrifield; L T Laatikainen; MC d'Emden; D C Crimet; R L O'Connell; P G Colman
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
Lancet 2007;370(9600):1687-97.
2007: Daniel B Mark; Frans Van de Werf; R John Simes; Harvey D White; Lars Wallentin; Robert M Califf; Paul W Armstrong
Cardiovascular disease on a global scale: defining the path forward for research and practice.
European heart journal 2007;28(21):2678-84.
2007: Ian C Marschner; R John Simes; Anthony C Keech
Biases in the identification of risk factor thresholds and J-curves.
American journal of epidemiology 2007;166(7):824-31.
2007: Martin R Stockler; Rachel O'Connell; Anna K Nowak; David Goldstein; Jane Turner; Nicholas Wilcken; david wyld; Ehtesham A Abdi; Amanda Glasgow; Philip Beale; Michael Jefford; Haryana Dhillon; Stephane Heritier; Candace Carter; Ian B Hickie; R John Simes
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
The lancet oncology 2007;8(7):603-12.
2007: John J Edmond; John K French; Philip E G Aylward; Cheuk-Kit Wong; Ralph A H Stewart; Barbara F Williams; Carmine G De Pasquale; R L O'connell; K Van den Berg; Frans Van de Werf; R John Simes; Harvey D White
Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2.
European heart journal 2007;28(12):1418-24.
2007: Val Gebski; Bryan H Burmeister; janine thomas; Kerwyn Foo; John Zalcberg; R John Simes
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.
The lancet oncology 2007;8(3):226-34.
2006: Anthony C Keech; R John Simes; Philip Barter; James Best; Russell Scott; Marja-Riitta Taskinen
Correction to the FIELD study report.
Lancet 2006;368(9545):1415.
2006: Martine Van Glabbeke; Jaap Verweij; Paolo G Casali; R John Simes; Axel Le Cesne; Peter Reichardt; Rolf Issels; Ian R Judson; Allan T van Oosterom; Jean-Yves Blay
Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: a study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG).
European journal of cancer (Oxford, England : 1990) 2006;42(14):2277-85.
2006: Roland Stocker; Christine Pollicino; Craig A Gay; Paul Nestel; David M Colquhoun; Malcolm Whiting; Andrew Tonkin; David Sullivan; R John Simes
Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study.
Atherosclerosis 2006;187(1):198-204.
2006: Sarah J Lord; Les Irwig; R John Simes
When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?
Annals of internal medicine 2006;144(11):850-5.
2006: Andrew M Tonkin; Simon D Eckermann; Harvey White; Denis Friedlander; Paul Glasziou; Paul Magnus; Adrienne Kirby; Sarah Mulray; Mary Denton; Michele Sallaberger; David Hunt; R John Simes
Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
American heart journal 2006;151(6):1305-12.
2006: Cheryl D Bushnell; Jeffrey Griffin; L Kristin Newby; Larry B Goldstein; Kenneth W Mahaffey; Carmelo Graffagnino; Robert A Harrington; Harvey D White; R John Simes; Robert M Califf; Eric J Topol; J Donald Easton
Statin use and sex-specific stroke outcomes in patients with vascular disease.
Stroke; a journal of cerebral circulation 2006;37(6):1427-31.
2006: John J Edmond; John K French; Ralph A H Stewart; Philip A Aylward; Carmine G De Pasquale; Barbara F Williams; Rachel L O'Connell; R John Simes; Harvey D White
Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques.
The American journal of cardiology 2006;97(7):947-51.
2006: Andrés Orlandini; Rafael Díaz; Daniel Wojdyla; Karen Pieper; Frans Van de Werf; Christopher B Granger; Robert A Harrington; Eric Boersma; Robert M Califf; Paul Armstrong; Harvey White; R John Simes; Ernesto Andres Cesar Paolasso
Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes.
European heart journal 2006;27(5):527-33.
2006: Sally Galbraith; Ian C Marschner; R John Simes
Missing data methods for the assessment of surrogate outcomes and treatment mechanisms in clinical trial substudies.
Statistics in medicine 2006;25(3):415-31.
2006: Martin R Stockler; Martin H N Tattersall; Michael J Boyer; Stephen J Clarke; Philip Beale; R John Simes
Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.
British journal of cancer 2006;94(2):208-12.
2006: Val Gebski; Marivic Lagleva; Anthony C Keech; R John Simes; Allan O Langlands
Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.
Journal of the National Cancer Institute 2006;98(1):26-38.
2006: Lisa Askie; Davina Ghersi; R John Simes
Prospective registration of clinical trials.
The Australian journal of physiotherapy 2006;52(4):237-9.
2005: Marcello Tonelli; Anthony C Keech; Jim Shepherd; Frank M Sacks; Andrew Tonkin; Chris Packard; Marc Pfeffer; R John Simes; Chris Isles; Curt D Furberg; Malcolm West; Timothy Craven; Gary Curhan
Effect of pravastatin in people with diabetes and chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2005;16(12):3748-54.
2005: S P Ackland; M Jones; D Tu; R John Simes; J Yuen; A-M Sargeant; Haryana Dhillon; Richard M Goldberg; Ehtesham A Abdi; L Shepherd; M J Moore
A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer.
British journal of cancer 2005;93(11):1236-43.
2005: Anthony C Keech; R John Simes; Philip Barter; James Best; Russell Scott; Marja-Riitta Taskinen; Peta Forder; A Pillai; T Davis; Paul Glasziou; P Drury; Y A Kesäniemi; D Sullivan; David Hunt; P Colman; MC d'Emden; M Whiting; C Ehnholm; M Laakso
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
Lancet 2005;366(9500):1849-61.
2005: Peter Sinnaeve; R John Simes; Salim Yusuf; Jyotsna Garg; Shamir Mehta; John Eikelboom; John A Bittl; Patrick Serruys; Eric J Topol; Christopher B Granger
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention.
European heart journal 2005;26(22):2396-403.
2005: Vlatka M Duric; Martin R Stockler; Stephane Heritier; Frances M Boyle; Jane Beith; A Sullivan; Nicholas Wilcken; Alan Coates; R John Simes
Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1786-94.
2005: Colin Baigent; A Keech; Patricia M Kearney; Lisa Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; Rory Collins; R John Simes
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Lancet 2005;366(9493):1267-78.
2005: Davina Ghersi; Nicholas Wilcken; R John Simes
A systematic review of taxane-containing regimens for metastatic breast cancer.
British journal of cancer 2005;93(3):293-301.
2005: Marcello Tonelli; Chris Isles; Timothy Craven; Andrew Tonkin; Marc A Pfeffer; James Shepherd; Frank M Sacks; Curt D Furberg; Stuart M Cobbe; R John Simes; Malcolm West; Chris Packard; Gary C Curhan
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.
Circulation 2005;112(2):171-8.
2005: Cheuk-Kit Wong; John K French; Philip E G Aylward; Ralph A H Stewart; Wanzhen Gao; Paul W Armstrong; Frans J J Van De Werf; R John Simes; O Christopher Raffel; Christopher B Granger; Robert M Califf; Harvey D White
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
Journal of the American College of Cardiology 2005;46(1):29-38.
2005: Paul J Nestel; Katrine Baghurst; David M Colquhoun; R John Simes; Kirsty Mehalski; Harvey D White; Andrew M Tonkin; Adrienne Kirby; Christine Pollicino
Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.
The American journal of clinical nutrition 2005;81(6):1322-9.
2005: Ralph A H Stewart; Harvey D White; Adrienne C Kirby; Stephane Heritier; R John Simes; Paul J Nestel; Malcolm J West; David M Colquhoun; Andrew M Tonkin
White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
Circulation 2005;111(14):1756-62.
2005: Russell Scott; James Best; Peta Forder; Marja-Riitta Taskinen; R John Simes; Philip Barter; Anthony C Keech
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
Cardiovascular diabetology 2005;4():13.
2005: Sue Carrick; S Parker; Nicholas Wilcken; Davina Ghersi; M Marzo; R John Simes
Single agent versus combination chemotherapy for metastatic breast cancer.
Cochrane database of systematic reviews (Online) 2005;(2):CD003372.
2005: Davina Ghersi; Nicholas Wilcken; R John Simes; E Donoghue
Taxane containing regimens for metastatic breast cancer.
Cochrane database of systematic reviews (Online) 2005;(2):CD003366.
2005: Marino Labinaz; Jasmine Mathias; Karen S Pieper; Christopher B Granger; A Michael Lincoff; David J Moliterno; Frans Van de Werf; R John Simes; Harvey D White; Maarten L Simoons; Robert M Califf; Eric J Topol; Paul W Armstrong; Robert A Harrington
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
European heart journal 2005;26(2):128-36.
2004: Marcello Tonelli; Chris Isles; Gary C Curhan; Andrew Tonkin; Marc A Pfeffer; James Shepherd; Frank M Sacks; Curt D Furberg; Stuart M Cobbe; R John Simes; Timothy Craven; Malcolm West
Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
Circulation 2004;110(12):1557-63.
2004: Hassan Kassem-Moussa; Kenneth W Mahaffey; Carmelo Graffagnino; Gudaye Tasissa; Cathy A Sila; R John Simes; Harvey D White; Robert M Califf; Manjushri Bhapkar; L Kristin Newby
Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
American heart journal 2004;148(3):439-46.
2004: R John Simes; Val J Gebski; Anthony C Keech
Subgroup analysis: application to individual patient decisions.
The Medical journal of Australia 2004;180(9):467-9.
2004: David M Colquhoun; Anthony C Keech; David Hunt; Ian C Marschner; R John Simes; Paul Glasziou; Harvey White; Philip Barter; Andrew Tonkin
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
European heart journal 2004;25(9):771-7.
2004: David E Kandzari; Christopher B Granger; Maarten L Simoons; Harvey D White; R John Simes; Kenneth W Mahaffey; Joel Gore; W Douglas Weaver; William T Longstreth; Amanda L Stebbins; Kerry L Lee; Robert M Califf; Eric J Topol
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
The American journal of cardiology 2004;93(4):458-61.
2004: S Lord; Davina Ghersi; M Gattellari; S Wortley; Nicholas Wilcken; R John Simes
Antitumour antibiotic containing regimens for metastatic breast cancer.
Cochrane database of systematic reviews (Online) 2004;(4):CD003367.
2004: Sue Carrick; Davina Ghersi; Nicholas Wilcken; R John Simes
Platinum containing regimens for metastatic breast cancer.
Cochrane database of systematic reviews (Online) 2004;(3):CD003374.
2004: Sue Carrick; Davina Ghersi; Nicholas Wilcken; R John Simes
Platinum containing regimens for metastatic breast cancer.
Cochrane database of systematic reviews (Online) 2004;(2):CD003374.
2003: Dianna J Magliano; Danny Liew; Helen Pater; Adrienne Kirby; David Hunt; R John Simes; Vijaya Sundararajan; Andrew Tonkin
Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study.
Australian and New Zealand journal of public health 2003;27(6):649-53.
2003: Judith M Kramer; L Kristin Newby; Wei Ching Chang; R John Simes; Frans Van de Werf; Christopher B Granger; Kerry L Lee; Harvey D White; Leopoldo Soares Piegas; Eric J Topol; Robert M Califf; Paul W Armstrong
International variation in the use of evidence-based medicines for acute coronary syndromes.
European heart journal 2003;24(23):2133-41.
2003: Ralph A H Stewart; Fiona M North; Teena West; Katrina J Sharples; R John Simes; David M Colquhoun; Harvey D White; Andrew M Tonkin
Depression and cardiovascular morbidity and mortality: cause or consequence?
European heart journal 2003;24(22):2027-37.
2003: Anthony C Keech; David M Colquhoun; James Best; Adrienne Kirby; R John Simes; David Hunt; Wendy Hague; Elaine Beller; Manjula Arulchelvam; Jennifer Baker; Andrew Tonkin
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
Diabetes care 2003;26(10):2713-21.
2003: Paul A Glare; Kiran Virik; Mark Jones; Malcolm Hudson; Steffen Eychmuller; R John Simes; Nicholas Christakis
A systematic review of physicians' survival predictions in terminally ill cancer patients.
BMJ (Clinical research ed.) 2003;327(7408):195-8.
2003: Rhana Pike; Anthony C Keech; R John Simes
Clinical trials research in the new millennium: the International Clinical Trials Symposium, Sydney, 21-23 October 2002.
The Medical journal of Australia 2003;178(7):316-7.
2003: Wendy Hague; Peta Forder; R John Simes; David Hunt; Andrew Tonkin
Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
American heart journal 2003;145(4):643-51.
2003: Simon D Eckermann; Andrew J Martin; Martin R Stockler; R John Simes
The benefits and costs of tamoxifen for breast cancer prevention.
Australian and New Zealand journal of public health 2003;27(1):34-40.
2003: Davina Ghersi; Nicholas Wilcken; R John Simes; E Donoghue
Taxane containing regimens for metastatic breast cancer.
Cochrane database of systematic reviews (Online) 2003;(3):CD003366.
2002: Malcolm J West; Harvey D White; R John Simes; Adrienne Kirby; John D Watson; Neil E Anderson; Graeme J Hankey; Susan Wonders; David Hunt; Andrew M Tonkin
Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin.
Journal of hypertension 2002;20(12):2513-7.
2002: Paul Glasziou; Simon D Eckermann; Sarah E Mulray; R John Simes; Andrew J Martin; Adrienne C Kirby; Jane P Hall; Susan Caleo; Harvey D White; Andrew M Tonkin
Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?
The Medical journal of Australia 2002;177(8):428-34.
2002: Peter Hersey; Alan Coates; William H McCarthy; John F Thompson; Robert W Sillar; Roderick McLeod; P Grantley Gill; Brendon J Coventry; Amanda McMullen; Haryana Dillon; R John Simes
Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(20):4181-90.
2002: L Kristin Newby; Robert A Harrington; Manjushri Bhapkar; Frans Van de Werf; Judith S Hochman; Christopher B Granger; R John Simes; Catherine G Davis; Eric J Topol; Robert M Califf; David J Moliterno
An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A.
Journal of thrombosis and thrombolysis 2002;14(1):33-42.
2002: Sana M Al-Khatib; Christopher B Granger; Yao Huang; Kerry L Lee; Robert M Califf; Maarten L Simoons; Paul W Armstrong; Frans Van de Werf; Harvey D White; R John Simes; David J Moliterno; Eric J Topol; Robert A Harrington
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
Circulation 2002;106(3):309-12.
2002: R John Simes; Ian C Marschner; David Hunt; David M Colquhoun; David Sullivan; Ralph A H Stewart; Wendy Hague; Anthony C Keech; Peter Thompson; Harvey White; John Shaw; Andrew Tonkin
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
Circulation 2002;105(10):1162-9.
2002: R John Simes; Curt D Furberg; E Braunwald; B R Davis; I Ford; Andrew Tonkin; J Shepherd
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
European heart journal 2002;23(3):207-15.
2002: eric boersma; Robert A Harrington; David J Moliterno; Harvey White; Pierre Théroux; Frans Van de Werf; Anneke de Torbal; Paul W Armstrong; Lars Wallentin; Robert G Wilcox; R John Simes; Robert M Califf; Eric J Topol; Maarten L Simoons
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
Lancet 2002;359(9302):189-98.
2001: T Lumley; R John Simes; Val Gebski; H M Hudson
Combining components of quality of life to increase precision and evaluate trade-offs.
Statistics in medicine 2001;20(21):3231-49.
2001: Ian C Marschner; David M Colquhoun; R John Simes; Paul Glasziou; P Harris; B B Singh; D Friedlander; Harvey White; P Thompson; Andrew Tonkin
Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators.
Journal of the American College of Cardiology 2001;38(1):56-63.
2001: G Lawrence; David Tudehope; K Baumann; H Jeffery; A Gill; M Cole; J Drew; A McPhee; J Ratcliffe; G Reynolds; R John Simes; C Swanson; D Cartwright; P Davis; I Humphrey; A Berry
Enteral human IgG for prevention of necrotising enterocolitis: a placebo-controlled, randomised trial.
Lancet 2001;357(9274):2090-4.
2001: David Hunt; P Young; R John Simes; Wendy Hague; S Mann; D Owensby; G Lane; Andrew Tonkin
Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
Annals of internal medicine 2001;134(10):931-40.
2001: Thomas Shakespeare; Val J Gebski; M J Veness; R John Simes
Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours.
Lancet 2001;357(9265):1349-53.
2001: Guy C Toner; Martin R Stockler; Michael J Boyer; M Jones; D B Thomson; V J Harvey; Ian N Olver; H Dhillon; A McMullen; Val J Gebski; J A Levi; R John Simes
Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.
Lancet 2001;357(9258):739-45.
2000: Andrew M Tonkin; David M Colquhoun; J Emberson; Wendy Hague; Anthony C Keech; G Lane; Stephen MacMahon; J Shaw; R John Simes; Peter L Thompson; H D White; David Hunt
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
Lancet 2000;356(9245):1871-5.
2000: Ralph A H Stewart; Katrina J Sharples; F M North; D B Menkes; J Baker; R John Simes
Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators.
Archives of internal medicine 2000;160(20):3144-52.
2000: Frank M Sacks; Andrew M Tonkin; J Shepherd; Eugene Braunwald; Stuart M Cobbe; C M Hawkins; Anthony C Keech; Chris Packard; R John Simes; Robert P Byington; Curt D Furberg
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project.
Circulation 2000;102(16):1893-900.
2000: Eric J Topol; Erik Ohman; Paul W Armstrong; Robert Wilcox; A M Skene; Philip E Aylward; R John Simes; A Dalby; Amadeo Betriu; C Bode; Harvey D White; Judith S Hochman; H Emanuelson; A Vahanian; Shelly K Sapp; Amanda L Stebbins; David J Moliterno; Robert M Califf
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.
Circulation 2000;102(15):1761-5.
2000: Harvey D White; R John Simes; N E Anderson; Graeme J Hankey; J D Watson; D Hunt; David M Colquhoun; Paul Glasziou; S MacMahon; Adrienne C Kirby; Malcolm J West; Andrew M Tonkin
Pravastatin therapy and the risk of stroke.
The New England journal of medicine 2000;343(5):317-26.
2000: Martin R Stockler; Nicholas Wilcken; Davina Ghersi; R John Simes
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer.
Cancer treatment reviews 2000;26(3):151-68.
2000: Andrew J Martin; Paul P Glasziou; R John Simes; T Lumley
A comparison of standard gamble, time trade-off, and adjusted time trade-off scores.
International journal of technology assessment in health care 2000;16(1):137-47.
1999: A J Martin; Paul Glasziou; R John Simes
A cardiovascular extension of the Health Measurement Questionnaire.
Journal of epidemiology and community health 1999;53(9):548-57.
1998: A J Martin; Paul Glasziou; R John Simes; T Lumley
Predicting patients' utilities from quality of life items: an improved scoring system for the UBQ-H.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1998;7(8):703-11.
1998: Stephen MacMahon; Norman Sharpe; Greg Gamble; H Hart; J Scott; R John Simes; H White
Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.
Circulation 1998;97(18):1784-90.
1998: R John Simes; V Greatorex; Val J Gebski
Practical approaches to minimize problems with missing quality of life data.
Statistics in medicine 1998;17(5-7):725-37.
1998: Jürg Bernhard; David Cella; Alan Coates; L Fallowfield; Patricia Anne Ganz; C M Moinpour; P Mosconi; David Osoba; R John Simes; Christoph Hürny
Missing quality of life data in cancer clinical trials: serious problems and challenges.
Statistics in medicine 1998;17(5-7):517-32.
1997: Paul Glasziou; R John Simes; J Hall; Cam Donaldson
Design of a cost-effectiveness study within a randomized trial: the LIPID Trial for Secondary Prevention of IHD. Long-term Intervention with Pravastatin in Ischemic Heart disease.
Controlled clinical trials 1997;18(5):464-76.
1997: J M Stern; R John Simes
Publication bias: evidence of delayed publication in a cohort study of clinical research projects.
BMJ (Clinical research ed.) 1997;315(7109):640-5.
1997: Michael J Byrne; Val Gebski; J Forbes; M H Tattersall; R John Simes; Alan Coates; Joanna Dewar; M Lunn; C Flower; P Grantley Gill; J Stewart
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(9):3141-8.
1997: Elaine Beller; Martin Tattersall; T Lumley; JA Levi; D Dalley; Ian N Olver; J Page; Ehtesham A Abdi; C Wynne; M Friedlander; D Boadle; HR Wheeler; S Margrie; R John Simes
Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(3):277-83.
1997: Eric J Topol; Robert M Califf; Frans Van de Werf; Maarten L Simoons; J Hampton; K L Lee; H White; R John Simes; Paul W Armstrong
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.
Circulation 1997;95(4):1072-82.
1996: J R Zalcberg; J Siderov; R John Simes
The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(1):42-6.
1995: R John Simes
Prospective meta-analysis of cholesterol-lowering studies: the Prospective Pravastatin Pooling (PPP) Project and the Cholesterol Treatment Trialists (CTT) Collaboration.
The American journal of cardiology 1995;76(9):122C-126C.
1995: R John Simes; Eric J Topol; D R Holmes; H D White; W R Rutsch; A Vahanian; M L Simoons; D Morris; A Betriu; Robert M Califf
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
Circulation 1995;91(7):1923-8.
1994: Paul Glasziou; S Bromwich; R John Simes
Quality of life six months after myocardial infarction treated with thrombolytic therapy. AUS-TASK Group. Australian arm of International tPA/SK Mortality Trial.
The Medical journal of Australia 1994;161(9):532-6.
1994: Kerry L Lee; Robert M Califf; R John Simes; Frans Van de Werf; Eric J Topol
Holding GUSTO up to the light. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Annals of internal medicine 1994;120(10):876-81; discussion 882-5.
1994: R John Simes
Low cholesterol and risk of non-coronary mortality.
Australian and New Zealand journal of medicine 1994;24(1):113-9.
1993: D F Signorini; O Leung; R John Simes; E Beller; V J Gebski; T Callaghan
Dynamic balanced randomization for clinical trials.
Statistics in medicine 1993;12(24):2343-50.
1993: Harvey D White; G I Barbash; M Modan; R John Simes; R Diaz; J R Hampton; J Heikkilä; A Kristinsson; S Moulopoulos; Ernesto Andres Cesar Paolasso
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study.
Circulation 1993;88(5 Pt 1):2097-103.
1993: Alan Coates; J Forbes; R John Simes
Prognostic value of performance status and quality-of-life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):2050.
1993: Stuart-Harris Robin; D Dalley; D R Bell; J Levi; R John Simes; E Wiltshaw
Ifosfamide combination regimens for soft-tissue sarcoma.
Cancer chemotherapy and pharmacology 1993;31 Suppl 2():S185-8.
1993: M Findlay; R John Simes; K Cox; K Carmichael; tien chey; E McNeil; D Raghavan
A randomised cross-over trial of antiemetic therapy for platinum-based chemotherapy. Improved control with an intensive multiagent regimen.
European journal of cancer (Oxford, England : 1990) 1993;29A(3):309-15.
1992: Rory Collins; A Keech; R Peto; P Sleight; J Kjekshus; L Wilhelmsen; S MacMahon; J Shaw; R John Simes; E Braunwald
Cholesterol and total mortality: need for larger trials.
BMJ (Clinical research ed.) 1992;304(6843):1689.
1992: R John Simes; P P Glasziou
Meta-analysis and quality of evidence in the economic evaluation of drug trials.
PharmacoEconomics 1992;1(4):282-92.
1990: Paul Glasziou; R John Simes; R D Gelber
Quality adjusted survival analysis.
Statistics in medicine 1990;9(11):1259-76.
1990: R John Simes
Meta-analysis: its importance in cost-effectiveness studies.
The Medical journal of Australia 1990;153 Suppl():S13-6.
1990: J Mackintosh; R John Simes; D Raghavan; B Pearson
Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare".
British journal of urology 1990;66(1):88-93.
1989: A Goldhirsch; Richard D Gelber; R John Simes; P Glasziou; A S Coates
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):36-44.
1988: Paul Glasziou; J Hilden; R John Simes
Single testing when two tests are available.
Medical decision making : an international journal of the Society for Medical Decision Making 1988;8(3):223-4.
1987: Stuart-Harris Robin; R John Simes; A S Coates; D Raghavan; R Devine; M H Tattersall
Patient treatment preference in advanced breast cancer: a randomized cross-over study of doxorubicin and mitozantrone.
European journal of cancer & clinical oncology 1987;23(5):557-61.
1986: R John Simes; M H Tattersall; A S Coates; D Raghavan; H J Solomon; H Smartt
Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer.
British medical journal (Clinical research ed.) 1986;293(6554):1065-8.
1986: S Klein; R John Simes; G L Blackburn
Total parenteral nutrition and cancer clinical trials.
Cancer 1986;58(6):1378-86.
1982: M W Davis; A L Vaterlaws; R John Simes; P Torzillo
Retinopathy in malaria.
Papua and New Guinea medical journal 1982;25(1):19-22.